trientine and Tremor
trientine has been researched along with Tremor in 5 studies
Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Sharawat, IK | 1 |
| Kurup, A | 1 |
| Sondhi, V | 1 |
| Saini, L | 1 |
| Burke, JF | 1 |
| Dayalu, P | 1 |
| Nan, B | 1 |
| Askari, F | 1 |
| Brewer, GJ | 1 |
| Lorincz, MT | 1 |
| Leinweber, B | 1 |
| Möller, JC | 1 |
| Scherag, A | 1 |
| Reuner, U | 1 |
| Günther, P | 1 |
| Lang, CJ | 1 |
| Schmidt, HH | 1 |
| Schrader, C | 1 |
| Bandmann, O | 1 |
| Czlonkowska, A | 1 |
| Oertel, WH | 1 |
| Hefter, H | 1 |
| Park, HK | 1 |
| Kim, SM | 1 |
| Choi, CG | 1 |
| Lee, MC | 1 |
| Chung, SJ | 1 |
| Suda, M | 1 |
| Kubota, J | 1 |
| Yamaguchi, Y | 1 |
| Fujioka, Y | 1 |
| Saito, Y | 1 |
| Aoki, T | 1 |
Other Studies
5 other studies available for trientine and Tremor
| Article | Year |
|---|---|
Boy with Dysarthria and Frequent Falls: A Treatable Disorder.
Topics: Accidental Falls; Brain; Chelating Agents; Child; Dysarthria; Hepatolenticular Degeneration; Humans; | 2019 |
Prognostic significance of neurologic examination findings in Wilson disease.
Topics: Adult; Chelating Agents; Dystonia; Female; Hepatolenticular Degeneration; Humans; Male; Molybdenum; | 2011 |
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Topics: Adult; Age of Onset; Antirheumatic Agents; Chelating Agents; Drug Therapy, Combination; Female; Germ | 2008 |
Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration.
Topics: Brain; Chelating Agents; Cognition Disorders; Disease Progression; Hepatic Encephalopathy; Humans; M | 2008 |
[A study of trientine therapy in Wilson's disease with neurological symptoms].
Topics: Adolescent; Adult; Dysarthria; Dystonia; Female; Hepatolenticular Degeneration; Humans; Male; Penici | 1993 |